67
Views
33
CrossRef citations to date
0
Altmetric
Original Research

High miR-454-3p expression predicts poor prognosis in hepatocellular carcinoma

, , , , &
Pages 2795-2802 | Published online: 08 Apr 2019

References

  • Llovet JM, Zucman-Rossi J, Pikarsky E, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2016;2:16018. doi:10.1038/nrdp.2016.1827158749
  • Panir K, Schjenken JE, Robertson SA, Hull ML. Non-coding RNAs in endometriosis: a narrative review. Hum Reprod Update. 2018;24(4):497–515. doi:10.1093/humupd/dmy01429697794
  • Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP. The impact of microRNAs on protein output. Nature. 2008;455(7209):64–71. doi:10.1038/nature0724218668037
  • Gonzalez-Duarte RJ, Cazares-Ordonez V, Avila-Chavez E. The microRNA biogenesis machinery: regulation by steroid hormones and alterations in cancer. Rev Invest Clin. 2014;66(5):460–464. 25695389
  • Santos JMO, Gil da Costa RM, Medeiros R. Dysregulation of cellular microRNAs by human oncogenic viruses – implications for tumorigenesis. Biochim Biophys Acta Gene Regul Mech. 2018;1861(2):95–105. doi:10.1016/j.bbagrm.2018.01.01729378330
  • Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215–233. doi:10.1016/j.cell.2009.01.00219167326
  • Gargalionis AN, Basdra EK. Insights in microRNAs biology. Curr Top Med Chem. 2013;13(13):1493–1502. 23745801
  • Shao Y, Liang B, Long F, Jiang S-J. Diagnostic microRNA biomarker discovery for non-small-cell lung cancer adenocarcinoma by integrative bioinformatics analysis. Biomed Res Int. 2017;2017:1–9. doi:10.1155/2017/2563085
  • Daniel R, Wu Q, Williams V, Clark G, Guruli G, Zehner Z. A panel of microRNAs as diagnostic biomarkers for the identification of prostate cancer. Int J Mol Sci. 2017;18(6):1281. doi:10.3390/ijms18061281
  • Cao Z-G, Li J-J, Yao L, et al. High expression of microRNA-454 is associated with poor prognosis in triple-negative breast cancer. Oncotarget. 2016;7(40):64900–64909. doi:10.18632/oncotarget.1176427588500
  • Wickham H. Ggplot2: Elegant Graphics for Data Analysis. Springer Publishing Company, Incorporated; 2009.
  • Team RDCJC. R: A Language and Environment for Statistical Computing. Vol. 14 Vienna (Austria): R Foundation for Statistical Computing; 2009:12–21.
  • Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545–15550. doi:10.1073/pnas.050658010216199517
  • Zhou L, Qu Y-M, Zhao X-M, Yue Z-D. Involvement of miR-454 overexpression in the poor prognosis of hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2016;20(5):825–829. 27010136
  • Aakula A, Kohonen P, Leivonen S-K, et al. Systematic identification of microRNAs that impact on proliferation of prostate cancer cells and display changed expression in tumor tissue. Eur Urol. 2016;69(6):1120–1128. doi:10.1016/j.eururo.2015.09.01926489476
  • Palma Flores C, Garcia-Vazquez R, Gallardo Rincon D, et al. MicroRNAs driving invasion and metastasis in ovarian cancer: opportunities for translational medicine (review). Int J Oncol. 2017;50(5):1461–1476. doi:10.3892/ijo.2017.394828393213
  • Granados-Lopez AJ, Ruiz-Carrillo JL, Servin-Gonzalez LS, et al. Use of mature miRNA strand selection in miRNAs families in cervical cancer development. Int J Mol Sci. 2017;18(2):407. doi:10.3390/ijms18020407
  • Pradillo M, Santos JL. Genes involved in miRNA biogenesis affect meiosis and fertility. Chromosome Res. 2018;26:233–241. doi:10.1007/s10577-018-9588-x30343461
  • Fu Q, Gao Y, Yang F, et al. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling. Biomed Pharmacother. 2018;97:120–127. doi:10.1016/j.biopha.2017.10.11529080452
  • Chambers AF, Werb Z. Invasion and metastasis–recent advances and future challenges. J Mol Med (Berl). 2015;93(4):361–368. doi:10.1007/s00109-015-1269-z25772709
  • Zhu D-Y, Li X-N, Qi Y, et al. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Biomed Pharmacother. 2016;81:79–85. doi:10.1016/j.biopha.2016.03.02927261580